Scrutinizing endpoints in ALS clinical trials: ALSFRS-R, Survival or a composite?

Are you wondering what would be the best primary endpoints for your ALS clinical trial? Then this free webinar recording, which we hosted in collaboration with our partner TRICALS, provides you with all the information you need.

In this webinar, our speakers discussed:

  • Primary endpoints in ALS clinical trials
  • Regulatory requirements: differences between EMA and FDA
  • Statistical considerations for ALSFRS-R, survival and composites